ArticleBMC musculoskeletal disorders2025
Comparison of Coflex dynamic stabilization with bacfuse static stabilization for lumbar degenerative disease.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo compare the clinical efficacy between BacFuse static interlaminar stabilization and Coflex dynamic interlaminar stabilization in patients with lumbar degenerative disease.
methodsSixty-one patents with lumbar degenerative disease who underwent Coflex and BacFuse interlaminar stabilization were included. Patient follow-up was conducted 1, 6, and 24 months after surgery.
resultsVisual analog scale scores, Oswestry Disability Index scores and Zurich Claudication Questionnaire scores were significantly improved after surgery in both groups. Anterior disc height, posterior disc height, and foramina height at the targeted segment increased after surgery in the BacFuse group by 11.69%, 22.88%, and 19.62%, respectively. Between the 1- and 24-month follow-ups, mean disc height of the segment superior to the target decreased from 18.92 ± 1.68 mm to 18.65 ± 1.94 mm in the Coflex group and from 19.52 ± 1.58 mm to 19.07 ± 1.40 mm in the BacFuse group (P < 0.05). No new symptoms developed during follow-up.
conclusionsBacFuse is a safe and effective alternative to Coflex interlaminar stabilization in patients with lumbar degenerative disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.